Michael P. Dillon Ideaya Biosciences, Inc. (IDYA) insider trading activity

Michael P. Dillon is SVP, Chief Scientific Officer of IDEAYA Biosciences, Inc.. Currently has a direct ownership of 78,789 shares of IDYA, which is worth approximately $2.1 Million. The most recent transaction as insider was on Oct 04, 2021, when has been sold 1,500 shares (Common Stock) at a price of $26.24 per share, resulting in proceeds of $39,360. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 78.8K

0% 3M change

0% 12M change

Total Value Held $2.1 Million

Michael P. Dillon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 04 2021	SELL Open market or private sale	$39,360 $26.24 p/Share	1,500 Reduced 1.87%	78,789 Common Stock
Oct 04 2021	BUY Exercise of conversion of derivative security	$16,620 $11.08 p/Share	1,500 Added 1.83%	80,289 Common Stock
Sep 08 2021	SELL Open market or private sale	$313,515 $27.54 p/Share	11,384 Reduced 12.62%	78,789 Common Stock
Sep 08 2021	BUY Exercise of conversion of derivative security	$87,657 $7.7 p/Share	11,384 Added 11.21%	90,173 Common Stock
Sep 07 2021	SELL Open market or private sale	$3,185 $27.46 p/Share	116 Reduced 0.15%	78,789 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$500 $4.31 p/Share	116 Added 0.15%	78,905 Common Stock
Sep 02 2021	SELL Open market or private sale	$250,900 $25.09 p/Share	10,000 Reduced 11.26%	78,789 Common Stock
Aug 09 2021	SELL Open market or private sale	$267,260 $23.24 p/Share	11,500 Reduced 11.47%	88,789 Common Stock
Aug 09 2021	BUY Exercise of conversion of derivative security	$6,465 $4.31 p/Share	1,500 Added 1.47%	100,289 Common Stock
Jul 27 2021	SELL Open market or private sale	$251,500 $25.15 p/Share	10,000 Reduced 9.19%	98,789 Common Stock
Jul 27 2021	BUY Exercise of conversion of derivative security	$56,200 $5.62 p/Share	10,000 Added 8.42%	108,789 Common Stock
Jul 06 2021	SELL Open market or private sale	$33,720 $22.48 p/Share	1,500 Reduced 1.5%	98,789 Common Stock
Jul 06 2021	BUY Exercise of conversion of derivative security	$10,380 $6.92 p/Share	1,500 Added 1.47%	100,289 Common Stock
Jun 17 2021	SELL Open market or private sale	$87,554 $22.49 p/Share	3,893 Reduced 3.79%	98,789 Common Stock
Jun 17 2021	BUY Exercise of conversion of derivative security	$26,940 $6.92 p/Share	3,893 Added 3.65%	102,682 Common Stock
Jun 16 2021	SELL Open market or private sale	$24,874 $22.47 p/Share	1,107 Reduced 1.11%	98,789 Common Stock
Jun 16 2021	BUY Exercise of conversion of derivative security	$7,660 $6.92 p/Share	1,107 Added 1.1%	99,896 Common Stock
Jun 07 2021	SELL Open market or private sale	$30,330 $20.22 p/Share	1,500 Reduced 1.5%	98,789 Common Stock
Jun 07 2021	BUY Exercise of conversion of derivative security	$10,380 $6.92 p/Share	1,500 Added 1.47%	100,289 Common Stock
May 11 2021	SELL Open market or private sale	$101,100 $20.22 p/Share	5,000 Reduced 4.82%	98,789 Common Stock
May 11 2021	BUY Exercise of conversion of derivative security	$34,600 $6.92 p/Share	5,000 Added 4.6%	103,789 Common Stock
Feb 09 2021	SELL Open market or private sale	$103,700 $20.74 p/Share	5,000 Reduced 4.82%	98,789 Common Stock
Feb 09 2021	BUY Exercise of conversion of derivative security	$34,600 $6.92 p/Share	5,000 Added 4.6%	103,789 Common Stock
Dec 18 2020	BUY Exercise of conversion of derivative security	$33,402 $4.31 p/Share	7,750 Added 7.27%	98,789 Common Stock

MPD

Michael P. Dillon

SVP, Chief Scientific Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDYA shares.

Notify only if

Value

Insider Trading

Get notified when an Ideaya Biosciences, Inc. insider buys or sells IDYA shares.

Notify only if

Operation

Value

Type

News

Receive news related to IDEAYA Biosciences, Inc.

Track Activities on IDYA

Account